Average Insider

Where insiders trade, we follow

$ORKA
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.
Healthcare
Sector
Biotechnology
Industry
Lawrence Otto Klein
CEO
28
Employees
$92.11
Current Price
$34.82M
Market Cap
52W Low$14.67
Current$92.1176.8% above low, 23.2% below high
52W High$115.52

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys00--All Sells
Sells25$7,346,585.6880,000
1 monthBuys00--All Sells
Sells415$13,770,876.69139,000
2 monthsBuys00--All Sells
Sells524$15,441,386.62156,000
3 monthsBuys00--All Sells
Sells642$317,694,045.193,737,400
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Jun 15, 2026
Goncalves Joana
Chief Medical Officer
Sale5,064$69.42$351,547.44View Details
Jun 15, 2026
Goncalves Joana
Chief Medical Officer
Sale947$69.69$65,996.43View Details
Jun 15, 2026
Klein Lawrence Otto
Director
Sale1,729$69.69$120,494.01View Details
Jun 15, 2026
Sandler Laura Lee
Chief Operating Officer
Sale600$69.69$41,814.00View Details
Jun 15, 2026
Quinlan Paul T
General Counsel
Sale733$69.69$51,082.77View Details
Jun 12, 2026
Dambkowski Carl
Director
Sale12,583$70.11$882,181.55View Details
41 more transactions available โ€” create a free account to see 12 months of history

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.

Related Activity

Cross-company insider connections and cluster buy signals
Version: v26.7.3